Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials

Raquel D Thalheimer1, Vanessa L Merker1, K Ina Ly1

  • 1From the Department of Neurology and Cancer Center (R.T., V.L.M., I.L., N.L.A., H.P.H., J.L.W.D., J.T.J., S.R.P.), Wellman Center for Photomedicine (A.C., J.S., E.M.P., F.H.S., R.R.A.), and Biostatistics Center (A.M.), Massachusetts General Hospital, and Department of Dermatology (A.C., J.S., E.M.P., F.H.S., R.R.A.), Harvard Medical School, Boston; and Department of Neurology, Neurosurgery, and Oncology (J.B.), Johns Hopkins University School of Medicine, Baltimore, MD.

Neurology
|July 7, 2021
PubMed
Abstract

Related Concept Videos